Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 4Sarcoma 2Breast 2Thoracic 1Lymphoid 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Urinary Retention 1

Interventions

Paclitaxel 575Carboplatin 521Cisplatin 351Bevacizumab 252pembrolizumab 228Gemcitabine 157Topotecan 128Cyclophosphamide 128liposomal doxorubicin 127olaparib 120Taxes 113Radiotherapy 110Docetaxel 94Brachytherapy 89Doxorubicin 84Drug Therapy 81niraparib 75Nivolumab 71Magnetic Resonance Spectroscopy 71Specimen Handling 65fludarabine 57Biopsy 55Hyperthermic Intraperitoneal Chemotherapy 53Filgrastim 52Letrozole 50Oxaliplatin 48durvalumab 47Immunoglobulin G 47atezolizumab 46Platinum 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Donepezil × Gynecologic × Clear all
NCT05540977 2022-09-15

Donepezil Prevents Urinary Retention After Extensive Total Hysterectomy

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase EARLY_PHASE1 Unknown
108 enrolled
Gynecologic

Uterine Cervical Neoplasms, Urinary Retention

Data powered by HemOnc (CC BY 4.0) Colophon âš¡